Opinions of Company Representatives About Neuromodulation

Completed

• Conditions: Neuromodulation; Pain; Survey
• Interventions: Behavioral: Filling in an online survey

• Registration Number: NCT05013827
• Lead Sponsor: Moens Maarten

Brief Summary

The goal of this online survey is to gain further insight in the goals, expectations and definition of success for neuromodulation for pain, according to neuromodulation company representatives.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2021-08-04
• Study First Submitted QC: 2021-08-18
• Study First Posted: 2021-08-19
• Study Start: 2021-09-02
• Primary Completion: 2021-09-09
• Study Completion: 2021-09-09
• Status Verified: 2022-01
• Last Update Submitted: 2022-01-13
• Last Update Posted: 2022-01-14

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 39

Inclusion Criteria

• Male and female adults who are involved in the management of chronic pain and more specifically in neuromodulation for pain as company representatives will be eligible to complete the survey.

Exclusion Criteria

• Not a company representative.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Company representatives	Filling in an online survey	-

Primary Outcome Measures

Name	Time	Method
Goals of company representatives, evaluated with a self-constructed question.	Cross-sectional evaluation during 2nd Joint Congress of the INS European Chapters (e-INS 2021) in Paris in September.	Goals of company representatives to treat patients with neuromodulation for pain.
Company representatives expectations, evaluated with a self-constructed question.	Cross-sectional evaluation during 2nd Joint Congress of the INS European Chapters (e-INS 2021) in Paris in September.	Factors that respondents expect to change according to neuromodulation for pain.
Company representatives definition of success of neuromodulation for pain, evaluated with a self-constructed question.	Cross-sectional evaluation during 2nd Joint Congress of the INS European Chapters (e-INS 2021) in Paris in September.	Company representatives their definition of success of neuromodulation for pain.

Trial Locations

Locations (1)

Vrije Universiteit Brussel; 🇧🇪 Jette, Belgium